The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells.
about
Circulating tumor cells isolation: the "post-EpCAM era"Cellular Plasticity in Prostate Cancer Bone MetastasisEpithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.Improved method increases sensitivity for circulating hepatocellular carcinoma cells.Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone.Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.Tumour budding in colorectal cancer: what do we know and what can we do?HOXB8 promotes tumor metastasis and the epithelial-mesenchymal transition via ZEB2 targets in gastric cancer.Circulating tumor cell technologies.Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis.Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.FGFs: crucial factors that regulate tumour initiation and progression.Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients.EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.Circulating Tumor Cells: Who is the Killer?Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy.Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-β receptor I in head and neck cancer.Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.Liquid biopsy provides new insights into gastric cancer.Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
P2860
Q26778917-9ABECFC4-2F7A-4788-800A-F0285A13D352Q28085013-B67E3DCA-61DD-4FA5-8888-4BF6DAC21E00Q34978807-DACF14E5-77C5-4FC7-8F52-2313BE432A3BQ35000278-8EB006CF-7578-4498-9C99-5E3E06A7EE73Q35169325-7DDBB734-E38A-4296-AE00-AB7D8CB67140Q35739519-2328D69B-5CAC-4E82-BA2D-A23D90F80238Q36212778-32F54E92-A36E-4652-8573-E587434D4D0AQ37269303-F88B5E06-C7B7-4458-8217-D7AD9872D41FQ38547813-4536C28F-CC33-49B3-9D50-A1770951FC57Q38650462-61EA2CEA-9223-4755-8DD4-E5DF2EFD13A3Q38739601-CF589ADD-4410-4EBC-B38E-5AFCBA217D9CQ38742272-19F42AA7-8421-4BEA-BF0A-059A675F6662Q38836736-19057921-F9AB-40B2-8261-9DA03E1A2A55Q38838108-FD7B61E4-40B8-4B2C-AC39-A41BC4E6208BQ38887615-87D21819-13FE-47FE-A5FA-FEBAB88FC32CQ38946859-41368933-CAD6-410B-9BC5-0D4ABECA292BQ39641921-22EA644A-0DF6-4A7C-A784-446FE7D53D95Q41472132-84CE82F9-BDFF-40B4-ADF6-850E61C33C86Q41697309-6F5DFE87-4B27-4484-9130-6E0E70F808D8Q41809872-72A83F64-8151-42B1-93CF-6668B7374812Q41836514-5CDBB217-90C6-4A27-B59E-17379A00EF14Q42199364-6F719760-5767-446F-A2EF-4A897C13A078Q44663325-03A2742C-4829-4469-8B25-75BCAA1D1841Q48225906-70CB42D3-8ACB-42C5-BEE1-AAC1326BDE1DQ49721184-DBAB9366-FDC8-4154-8AE4-25D988BDB73EQ52620413-FE9F9100-50B3-4C96-A003-6AC337CE2655Q53165899-48D9AE86-44B9-4D33-BEEC-6C0C30A4B20FQ55070669-F772ECA2-9900-4E30-AAFE-B68655151896Q55413893-267D4206-B43D-4D2D-8247-0C6AA6569C9E
P2860
The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The biological and clinical im ...... on in circulating tumor cells.
@en
type
label
The biological and clinical im ...... on in circulating tumor cells.
@en
prefLabel
The biological and clinical im ...... on in circulating tumor cells.
@en
P2093
P2860
P1476
The biological and clinical im ...... on in circulating tumor cells.
@en
P2093
Haihua Qian
Huiying Liu
Xiaofeng Zhang
Zhengfeng Yin
P2860
P2888
P304
P356
10.1007/S00432-014-1752-X
P577
2014-06-26T00:00:00Z